ChromaDex Balance Sheet Health
Financial Health criteria checks 6/6
ChromaDex has a total shareholder equity of $34.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $56.5M and $22.2M respectively. ChromaDex's EBIT is $447.0K making its interest coverage ratio -0.4. It has cash and short-term investments of $32.2M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -0.4x |
| Cash | US$32.25m |
| Equity | US$34.37m |
| Total liabilities | US$22.15m |
| Total assets | US$56.52m |
Recent financial health updates
Recent updates
ChromaDex's (NASDAQ:CDXC) Solid Earnings Are Supported By Other Strong Factors
Nov 07
Revenues Tell The Story For ChromaDex Corporation (NASDAQ:CDXC) As Its Stock Soars 70%
Nov 05ChromaDex Corporation (NASDAQ:CDXC) Stock Rockets 25% But Many Are Still Ignoring The Company
Jul 25Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable
Jun 15Positive Sentiment Still Eludes ChromaDex Corporation (NASDAQ:CDXC) Following 26% Share Price Slump
Jun 05Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?
Apr 05Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet
Feb 28ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price
Jan 29Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues
Jun 08We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely
Mar 31ChromaDex inks new commercial supply agreement for its Niagen ingredient with Nestlé
Oct 11ChromaDex forms JV in Asia for Tru Niagen; plans to raise $3.1M via stock sale
Oct 03ChromaDex in pact to introduce anti-aging compound in Brazil
Sep 01Ayana Bio appoints Frank Jaksch as CEO
Aug 24ChromaDex wins patent challenge as US regulator rejects Thorne Research's demand to invalidate patent
Aug 15Financial Position Analysis
Short Term Liabilities: CDXC's short term assets ($52.1M) exceed its short term liabilities ($17.7M).
Long Term Liabilities: CDXC's short term assets ($52.1M) exceed its long term liabilities ($4.5M).
Debt to Equity History and Analysis
Debt Level: CDXC is debt free.
Reducing Debt: CDXC had no debt 5 years ago.
Debt Coverage: CDXC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CDXC has no debt, therefore coverage of interest payments is not a concern.